Cardio-oncology & otherCohort study

COVID-19 vaccination and risk of post-COVID-19 cardiovascular disease: a population-based cohort and target trial emulation study

Eur Heart J Qual Care Clin OutcomesPublished

  • statewide population-based cohort study
  • linked administrative health data
  • time-varying Cox proportional hazards regression
  • causal mediation analysis
  • target trial emulation

Authors' conclusion

Vaccination before or after SARS-CoV-2 infection was associated with lower hazards of post-COVID-19 cardiovascular outcomes, with stronger observed associations at higher dose numbers. Most of the estimated association was not explained by infection prevention alone. These findings support COVID-19 vaccination as an important component of strategies to reduce the burden of post-COVID-19 CVD while highlighting the need for further studies to clarify the mechanisms underlying these associations.

Study context

Population
Adults in Victoria, Australia (2019–25)
Participants
2,391,456 adults
Exposure
Associations of pre- or post-infection vaccination with major adverse cardiovascular events
Outcome
major adverse cardiovascular events (MACE)

Main finding

As reported in the abstract

Estimated absolute risk reduction for major adverse cardiovascular events (MACE) with pre-infection vaccination

0.21%

Estimated absolute risk reduction for MACE with post-infection vaccination

0.24%

Observational data: associations, not effects.

Secondary outcomes

stroke, heart failure, acute myocardial infarction, acute coronary syndrome, atrial fibrillation, and venous thromboembolism

Vaccination was associated with lower hazards of all secondary outcomes

Cardiovascular outcomes by number of vaccine doses

Three or more vaccine doses were associated with progressively lower hazards across cardiovascular outcomes

Mediation by prevention of SARS-CoV-2 infection

Share of the estimated association between vaccination and lower post-COVID cardiovascular risk not explained by prevention of SARS-CoV-2 infection
∼68%

Original publication

COVID-19 vaccination and risk of post-COVID-19 cardiovascular disease: a population-based cohort and target trial emulation study. Eur Heart J Qual Care Clin Outcomes. Published 30 August 2026. doi:10.1093/ehjqcco/qcag139

Summarised from the published abstract; every number is checked against it